skip to main | skip to sidebar

Betty health

As new parents, let us give you some advice. Click below and save yourself some cash with $500 worth of free* Huggiesr or Pampersr Diapers and Wipes. Then again, you probably already know it's good to save where you can.

Wednesday, April 1, 2009

FDA Advisers Support Avastin for Brain Cancer

The biotech drug has already been used off-label for the disease.
Posted by Betty at 7:48 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ▼  2009 (958)
    • ►  August (18)
    • ►  July (123)
    • ►  June (129)
    • ►  May (117)
    • ▼  April (116)
      • Free From Uncle Sam: VA Software for Hospital EHS ...
      • Companies Look to Shift More Health Costs to Workers
      • Live Blog: CDC Swine-Flu Update
      • Live Blog: CDC Swine Flu Update
      • Medicare May Pay More For Primary-Care Docs, Rural...
      • Tracking the Swine Flu Outbreak: Thursday
      • Provenge Data Give Dendreon a Takeover Glow
      • Considering the Range of Pandemics
      • Live Blog: Swine Flu Update from WHO Director-General
      • Live Blog: Swine Flu Update from WHO Director-Gene...
      • Live Blog: Swine Flu Update from WHO Director-General
      • Swine Flu? H1N1? What’s In a Name?
      • After Yesterday’s Storm, Sun Shines Again on Dendr...
      • Search for Swine Flu’s Patient Zero Leads to Mexic...
      • After Swearing In, Sebelius Talks Swine Flu in Sit...
      • Plunging Stock Price Rains on Dendreon’s Provenge ...
      • Swine Flu: Live Blogging CDC’s Tuesday Call
      • Headless Health Agencies Face Swine Flu
      • IOM Talks Softly, Carries Big Stick on Doctor Conf...
      • Live Blog: WHO Tuesday Call
      • Pfizer Roundup: Lipitor Sales Fall, Biotech Chief ...
      • A Century of Flu Pandemics
      • Amid Swine Flu Outbreak, N95 Masks Placed on Back ...
      • Swine Flu at Alert Phase 4: ‘Mitigation,’ Not ‘Con...
      • If Primary-Care Docs Are Paid More, Will Specialis...
      • Understanding the WHO’s Global Pandemic-Alert Levels
      • Swine Flu: Live Blogging CDC’s Monday Conference Call
      • Glaxo, Roche Start to Map Swine-Flu Game Plans
      • What’s Confusing About Swine Flu
      • Health Blog Q&A: Swine Flu in the U.S. and Mexico
      • Abbott Shareholders Don’t Want Say On Exec Pay
      • Number of Malpractice Suits Falls 41% in Pennsylvania
      • As Insurance Coverage Increases, ERs Get Busier
      • War Against Cancer: A Long, Hard Slog
      • Swine Flu: Look Hard Enough, and You’ll See Strang...
      • Embryonic Stem Cells Without Embryos, Cont’d
      • Pfizer Holders Want Say on Exec Pay; J&J Holders, ...
      • Patients: There’s Waste in Medicine, but My Doctor...
      • Specialty Matters When Implanting Defibrillators
      • Boston Medical School in Awkward Spot After Craigs...
      • Does Avastin Trial Mean Roche Paid Too Much for Ge...
      • Sebelius Wins Committee Vote Despite Abortion Cont...
      • Where Medical Boards Do and Don’t Crack Down on Do...
      • Merck Suffers Blow Developing New Migraine Drug
      • Debate Over Public Plan Pulls Health Reform Past ‘...
      • 10 Reasons Doctors Get Burned Out
      • As Nest Eggs Shrink, Some Doctors Try to Return Fr...
      • WellPoint Makes Three Million Calls In Health-Refo...
      • Amid Talk of Reform, Health-Clinic Lines Grow
      • Friendlier Skies in Canada for Overweight Passengers
      • Universal Care Could Be Thwarted by Disappearing Docs
      • Silicone Can Carry High Cost in Bid to Look Good
      • Trying to Fill In the Blanks in FDA’s Rules on Web...
      • Feds: Watch Out for Exploding Fitness Balls
      • Roche and Genentech Break Down Some R&D Walls
      • Eli Lilly Tops List of Drug-Company Pay to Vermont...
      • Pharma Sales Reps Often Find the Doc Won’t See The...
      • Fresh Off Wyeth Deal, Pfizer Inks HIV Pact with Glaxo
      • Nancy-Ann DeParle’s Definition of ‘Public’ Health ...
      • Study Author in JAMA Disclosure Flap Has His Say
      • Abbott CEO: ‘We’re Not Necessarily Looking for any...
      • Merck Exec on R&D: ‘Nothing Is Safe From Cuts’
      • Roche Exec Takes Over As Genentech CEO
      • After Falling for Fake Study, Review Board Steps A...
      • Dendreon’s Shares Come Back to Life on Prostate Ca...
      • Diabetics Visiting the ER Have Greater Chance of D...
      • Generics, Recession Take Bites Out of J&J’s Profit
      • Finding Referrals for Mental-Health Patients Often...
      • Drug Makers Talk Up Comparative Effectiveness, Sor...
      • Heart Health: Mediterranean Diet Good, Trans Fats Bad
      • How Much Will Higher Taxes, Price Hikes Damp Cigar...
      • What the Recession Means for Hospitals, Nurses
      • Fraud Hits Home Health-Care Program
      • What the Recession Means for Hospitals, Nurses
      • Fraud Hits Home Health-Care Program
      • What’s the Best Way to Manage Prescription-Drug Be...
      • Icahn Tries to Shake Up Boards at Amylin and Biogen
      • Researcher Faked Data in Sleep Apnea Study
      • Harvard-Affiliated Hospitals to Limit Docs’ Indust...
      • Bristol, Biogen CEOs: We’re Not Rushing to Be Acqu...
      • Reality Check on Foodborne Illness Rate
      • Girl With Genetic Disease Sues Sperm Bank
      • Hospital Settles Over ‘Dumping’ Homeless Patients
      • Big Pharma’s Global Generics Push Continues With S...
      • Wait, What Is Brown Fat?
      • Time for Soda Tax? Backers Want to Cut Obesity, Ai...
      • FDA Takes New Look at Female Condoms, External Def...
      • Johns Hopkins Bans Free Drug Samples, Gifts from I...
      • Illegal Immigrant Used Stolen Identity to Get Hosp...
      • How Quality-of-Care Rules Can Lead Doctors Astray
      • If China Builds Hospitals, Patients Will Come
      • More Prescriptions for Generics, Fewer for Branded...
      • Shares of Medicare Advantage Companies Rise On New...
      • Reorganizing Drug R&D: $62 Billion Merger Not Requ...
      • Reorganizing Big Pharma R&D: $62 Billion Merger No...
      • Citing Economy, AMA Announces 100 Layoffs
      • Torti’s Farewell Memo to FDA Staff: ‘Take the FDA ...
      • Does the World Need a Prescription Drug for Jet Lag?
      • Abortion Foes Call Republican Response to Sebelius...
      • Pfizer Closes In on Settlement Over Drug Trial of ...
      • Abilify Deal Gives Bristol-Myers Some Breathing Room
      • Oops! Seroquel Documents Bounce On and Off FDA Web...
      • What FDA Diabetes Panel’s Novo Nordisk Vote Means ...
      • Nurse Charged With Killing Dialysis Patients With ...
      • Sebelius Nomination May Shift to Slow Track
      • Tobacco’s Regulator May Soon Be Same As Pharma’s
      • GE, Intel, Google, IBM, Microsoft & Home-Health Mo...
      • Testing of Alzheimer’s Treatment Is Curbed by Wyet...
      • Conservative Critic of Obama on Health Reform Has ...
      • Hospital Doors Revolve for Many Medicare Patients
      • Is Earlier Better for AIDS Treatment?
      • Potential Buyers Kick the Tires of Solvay’s Drug B...
      • Television Viewers Offer Kidneys to Natalie Cole
      • FDA Advisers Support Avastin for Brain Cancer
      • Sebelius Runs Into Tax Problems, But Daschle’s Wer...
      • As Angioplasty Declines, Are Patients Helped or Ha...
    • ►  March (174)
    • ►  February (144)
    • ►  January (137)
  • ►  2008 (1352)
    • ►  December (159)
    • ►  November (172)
    • ►  October (139)
    • ►  September (133)
    • ►  August (115)
    • ►  July (141)
    • ►  June (132)
    • ►  May (156)
    • ►  April (151)
    • ►  March (54)